Business Wire

B Medical Systems Significantly Expands Manufacturing Capacity to Support COVID Vaccination Campaign Worldwide

Share

B Medical Systems, a global leader in the vaccine cold chain, has significantly expanded its production capacity at its Luxembourg facility. The global roll-out of COVID-19 vaccines created an unprecedented demand for vaccine cold chain solutions and expansion of the production facility was necessary to meet the global demand. The new factory expansion of around 4,500 m2 was built in six months and will create around 150 additional jobs. The expansion will help the company double its production capacity for vaccine cold chain units and increase production capacity for Ultra-Low Freezers fivefold.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211007005554/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The Refrigerated Vaccine Transport Vehicle (Photo: B Medical Services)

B Medical Systems’ ultra-low freezers, vaccine refrigerators/freezers, laboratory refrigerators/ freezers, and transport boxes can store and transport COVID-19 vaccines at various temperature profiles ranging from -80°C to 8°C. The company has provided more than 70,000 cold chain units to 140+ countries for their effective COVID-19 immunization programs. B Medical Systems is also the exclusive supplier of Luxembourg’s COVID-19 vaccine cold chain solution.

Especially for vaccinating people in hard-to-reach areas, B Medical Systems together with Toyota Tsusho Corporation (TTC) has developed the Refrigerated Vaccine Transport Vehicle (RVTV). This is the very first refrigerated vehicle in the world to be PQS pre-qualified by the WHO and can be used to reliably transport vaccines or other specimens in a temperature range of 2-8°C. The vehicle will provide invaluable logistical support for the delivery of vaccines to regions where the Covid vaccine is being rolled out, including Africa and Latin America.

On this occasion, Mr. Luc Provost, CEO of B Medical Systems said, “Today is a major milestone for us. The production capacity expansion reflects our strong commitment to the world in ensuring reliable medical cold chain solutions with the shortest lead times. Our aim is to make Luxembourg, a global leader in the end-to-end medical cold chain industry, and this facility takes us one step closer to realizing this dream”

B Medical Systems also manufactures blood management solutions that are used by the clinical sector and blood /transfusion segment across the world. The company has 40+ years of experience in providing reliable cold chain solutions and works with humanitarian organizations like UNICEF, Red Cross, etc, ministries of health, hospitals, research institutes, pharmaceutical companies across the world. The company has regional subsidiaries in the United States and India.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press Contact
Lekshmi Padmavathy
Lekshmi.Padmavathy@bmedicalsystems.com
+352-661-365-163

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LTIMindtree Collaborates with Vodafone to Deliver Connected, Smart IoT and Industry X.0 Solutions18.4.2024 11:00:00 CEST | Press release

LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has collaborated with Vodafone, a global leader in managed Internet of Things (IoT), with over 175 million connections worldwide, supporting a wide range of business-critical applications. Through this partnership, LTIMindtree will offer connected and smart IoT solutions, powered by its Insight NXT platform (iNXT) and Vodafone’s IoT Managed Connectivity, that will enable Industry X.0 and digital transformation across multiple vertical sectors. LTIMindtree’s iNXT Business Unit brings Technical and Functional components, and together with Vodafone’s IoT Managed Connectivity solutions it will deliver to solve complex business challenges. By drawing on a best-in-class ecosystem of partners, LTIMindtree will empower clients to maximize their efforts across revenue acceleration through newer business models, cost efficiency and sustainability, leveraging Smart IoT and Industry X.0. LTIMindtree

Looming Deadline for SAP ECC Prompts Nordic Firms to RISE18.4.2024 10:00:00 CEST | Press release

As the clock winds down on SAP’s support for its ERP Central Component (ECC) system, adoption of the company’s RISE with SAP offering is on the upswing among Nordic enterprises, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm. The 2024 ISG Provider Lens™ SAP Ecosystem report for the Nordics finds a notable increase in demand from large enterprises over the past 12–18 months for both on-premises and cloud deployment of S/4HANA. Much of that increase can be attributed to the RISE with SAP program, which offers tools, services and software to help large enterprises adopt SAP solutions, the ISG report says. SAP is pushing companies to implement S/4HANA as it ends support for its on-premises SAP ECC system at the end of 2027. “Growing interest among Nordic businesses in RISE with SAP has increased demand for managed cloud services outsourcing,” said Andreas Fahr, partner and head of

SiAT Partners with Zeon to Launch Innovative SWCNT Conductive Paste, Enhancing Battery Fast Charging and Energy Density18.4.2024 09:00:00 CEST | Press release

SiAT, a leading Taiwan manufacturer of advanced nanomaterials for batteries, is excited to announce a strategic partnership with Japan's Zeon Corporation. This collaboration marks the introduction of single-walled carbon nanotube conductive paste. The product can replace or be combined with carbon black to serve as a conductive agent additive in Lithium-ion battery cathode/anode formulations, and also has wide applications in transparent films and EMI shielding. Zeon produces single-walled carbon nanotubes (SWCNT) that demonstrate unique properties, including high aspect ratio, high purity and high specific surface area. Zeon is one of the few earliest SWCNT manufacturers and has achieved mass production since 2015. CNT tends to undergo bundling and lack of dispersibility in aqueous and nonaqueous media. Nanomaterial dispersion has always been a difficult problem to overcome. SiAT has the unique technology know-how experience and production capacity in the application of nanomaterial d

NILIT Announces Strategic Expansions, Including a Joint Venture with Shenma in China18.4.2024 05:30:00 CEST | Press release

NILIT, the global leader in high-performance Nylon 6.6 fibers for the apparel industry and leader in sustainability, that owns the broadest line of sustainable Nylon 6.6 products, is announcing a new joint venture with Shenma Industry Co., Ltd. (hereinafter referred to as Shenma), a subsidiary of China Pingmei Shenma Group, a global leader in the industrial Nylon 6.6 market and a leading supplier to the automotive industry around the world. This new partnership represents a significant expansion of production capacity within China, also demonstrating NILIT’s ongoing commitment to support the growth of global customers and brands. This expansion is highlighted by multiple investments and cooperation designed to enhance production capabilities and deliver more innovative solutions to the textile industry. “We are pleased to unveil this new greenfield joint venture in China with Shenma to introduce differentiated state-of-the-art technologies to support the local market,” says Ilan Melame

The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report18.4.2024 01:01:00 CEST | Press release

A new report published today reveals that adult vaccination programmes can return up to 19 times their initial investment when the full spectrum of economic and societal benefits is valued. The 19x return is equivalent to up to USD 4,637 in net monetary benefits to society per individual full vaccination course. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240417519822/en/ Learn more about the economic benefits of investing in adult immunisation programmes in a new study by the Office of Health Economics (OHE). Graphic: OHE The study, a first-of-its-kind analysis of adult immunisation programmes by the Office of Health Economics (OHE) and commissioned by IFPMA (1), looked at four adult vaccines across ten countries where they are available to determine the wider economic and social impact. Focusing on vaccines that protect against influenza (flu), pneumococcal disease, respiratory syncytial virus (RSV), and herpes zoster (

HiddenA line styled icon from Orion Icon Library.Eye